Introduction: The purpose of this study was to explore the main factors explaining the relative weight of the different attributes that determine the value of oncologic treatments from the different perspectives of healthcare policy makers (HCPM), oncologists, patients and the general population in Spain.
Methods: Structured interviews were conducted to assess: (1) the importance of the attributes on treatment choice when comparing a new cancer drug with a standard cancer treatment; (2) the importance of survival, quality of life (QoL), costs and innovation in cancer; and (3) the most worrying side effects related to cancer drugs.
Results: A total of 188 individuals participated in the study. For all participants, when choosing treatments, the best rated characteristics were greater efficacy, greater safety, treatment adaptation to patients' individual requirements and the rapid reincorporation of patients to their daily activities. There were important differences among participants in their opinion about survival, QoL and cost. In general, oncologists, patients, and the general population gave greater value to gains in QoL than healthcare policy makers. Compared to other participants healthcare policy makers gave greater importance to the economic impact related to oncology treatments.
Conclusions: Gains in QoL, survival, safety, cost and innovation are perceived differently by different groups of stakeholders. It is recommended to consider the perspective of different stakeholders in the assessment of a new cancer drugs to obtain more informed decisions when deciding on the most appropriate treatment to use.
Funding: Eli Lilly & Co, Madrid (Spain).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083772 | PMC |
| http://dx.doi.org/10.1007/s12325-016-0415-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Experiences of African women who migrate to a developed country and encounter intimate partner violence: a systematic review of qualitative evidence.
JBI Evid Synth
January 2025
School of Nursing and Midwifery, University of Newcastle, Newcastle, New South Wales, Australia.
Objective: The objective of this review was to synthesize the available evidence on the experiences of African women who migrated to a developed country and encountered intimate partner violence (IPV).
Introduction: IPV is a significant public health issue, and migrant women living in developed countries are particularly vulnerable to IPV, experiencing disproportionately higher rates of IPV. Understanding the experiences of these women can inform health policy and decision-making in clinical practice to minimize IPV.
The Environmental and Public Health Benefits of Offshore Wind Power Deployment in China.
Environ Sci Technol
January 2025
China Three Gorges Corporation, Beijing 100038, China.
With the rapid decline in the levelized cost, offshore wind power offers a new option for the clean energy transition of the power sector in China's coastal areas. Here, we develop a power system capacity expansion and operation optimization model to simulate the penetration of offshore wind power in China and quantify the associated health effects. We find that offshore wind power has great potential in mitigating the negative impacts of existing coal-fired power emissions.
View Article and Find Full Text PDFExamining consumer preferences for basic foodstuffs in a highly inflationary economic environment: The case of price-capped chicken breast fillet in Hungary.
Heliyon
January 2025
Coordination Center for Research in Social Sciences, Faculty of Economics and Business, University of Debrecen, Böszörményi út 138., 4032, Debrecen, Hungary.
In recent months, the European Union has experienced inflation that has not been seen for decades. Inflation and inflation expectations are crucial in economic and purchasing behaviour, as they influence consumption. Hungary had the highest inflation among the Member States of the European Union.
View Article and Find Full Text PDFThe Safety of Multiple-Dose Liquid Blend Containing Kava and Kratom in Healthy Adults.
Cureus
December 2024
Clinical Pharmacology, Botanic Tonics, LLC, Calabasas, USA.
This study investigates the safety of three different daily dosages of a liquid blend containing kava and kratom (Feel Free® Classic Tonic {FFCT}) in healthy adults over six consecutive days of supplementation. Both kava and kratom have been used traditionally for hundreds of years, but there is limited data on the combined safety of these ingredients. In this randomized, double-blind, placebo-controlled trial, the participants were assigned to receive one of three daily dosages of FFCT or placebo.
View Article and Find Full Text PDFThe potential impact of climate change on medication access and quality deserves far more attention.
One Health
June 2025
Department of Global Health, Boston University School of Public Health, Boston, MA, United States of America.
Notwithstanding the obvious interconnection between humans and the world that they share with non-human inhabitants, the impact of our changing climate on certain aspects of the public health ecosystem has been under-investigated. We briefly describe some of the possible climate-induced changes in the procurement, distribution, access and use of medications, including those for animals generally and livestock specifically. A fuller understanding of the effect of climate change on medicine supply, access, use and quality, including how these affect antimicrobial resistance, would contribute to the further development of the "One Health" and "One Health Systems" concepts.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!